YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Roche Bids Again for Illumina?


December 21, 2012 | A Swiss newspaper is reporting that Roche and Illumina may have come to a purchase agreement, eight months after Illumina rejected Roche's last proposed bid. The two companies will announce a January $66/share sale price, the paper reported, though it said the information couldn't be verified. Analysts are very skeptical and neither company will comment. Bloomberg 

Update: Matthew Herper at Forbes contends that if Roche is bidding again for Illumina, Jay Flatley, Illumina's CEO, is the main asset. Forbes

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.